---
schema_version: "secwatch.filing_event.v1"
accession: "0000075252-23-000050"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:52:27.762887+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor Q3 revenue up 3.8% to $2.59B; adjusted EPS $0.44, debt cut $188M

## Summary
- Revenue $2.59B vs $2.497B in Q3 2022, driven by Patient Direct and Medical Distribution growth.
- GAAP net loss per share $(0.08); adjusted net income per share $0.44.
- Total debt paydown of $188M; net debt reduced by $117M.
- Patient Direct outperformed market; Medical Distribution posted mid-single digit growth.
- Operating Model Realignment Program delivered economic benefits; cautious on long-term PPE trajectory.

## SEC filing metadata
- accession: 0000075252-23-000050
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/0000075252-23-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/omi-20231103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000075252-23-000050
- JSON: https://secwatch.observer/filing/0000075252-23-000050.json
- Plain text: https://secwatch.observer/filing/0000075252-23-000050.txt

## Key facts
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported nine months ended September 30, 2023 results: revenue $7,678.
  - Period: nine months ended September 30, 2023
  - Revenue: $7,678
  - Result: reported results
  source text: YTD YTD ($ in millions, except per share data) 3Q23 3Q22 2023 2022 Revenue $2,592 $2,497 $7,678 $7,404 Operating income, GAAP $23.8 $60.2 $44.5 $196.4
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/0000075252-23-000050-index.htm
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported third quarter ended September 30, 2023 results: revenue $2.59 billion, net income Net loss per common share of $(0.08), EPS $(0.08).
  - Period: third quarter ended September 30, 2023
  - Revenue: $2.59 billion
  - Net income: Net loss per common share of $(0.08)
  - EPS: $(0.08)
  - Result: reported results
  source text: 2023 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: • Consolidated revenue of $2.59 billion • Net loss per common share of $(0.08) and adjusted net income per common share of $0.44 • $188 million in total debt pay down and $117 million reduction in net debt “Our
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/0000075252-23-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.